Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
What is the Expected Growth Rate of the Interventional Oncology Devices Market from 2024 to 2033?
In the past few years, there has been a considerable expansion in the market size of interventional oncology devices. The market is expected to surge from $2.35 billion in 2023 to $2.5 billion in 2024, demonstrating a compound annual growth rate (CAGR) of 6.4%. The historic growth of this market has been driven by factors such as an ageing population, a rise in the occurrence of cancer, an uptick in pharmaceutical research and development spending, growth in healthcare expenditures, and an increase in the number of healthcare facilities.
The market for interventional oncology devices is projected to experience significant expansion in the forthcoming years, increasing to a value of $3.25 billion in 2028 with a CAGR of 6.7%. This anticipated growth over the forecast period can be credited to factors such as an aging population, the rising preference for minimally invasive surgeries, increased spending on research and development, escalating healthcare costs, high opportunities in upcoming economies, and a growing incidence of cancer and chronic illnesses. Predominant trends for the forecast period entail the emphasis on the creation of advanced image-guided oncology devices, employing AI to invent ground-breaking devices, researching and developing novel embolic devices to facilitate superior oncology procedures, focusing on the application of robotic technology, and joining forces with other corporations and research institutions to expedite product enhancement and innovation.
Claim Your Free Sample of the Global Interventional Oncology Devices Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=3304&type=smp
What Key Factors Are Fueling the Growth of the interventional oncology devices Market?
A combination of private and public funding avenues have propelled the evolution of the interventional oncology devices market. The financial backing, specifically for innovation in cancer solutions, triggers early cancer detection and promotes higher survival rates. A prime example is the American Cancer Society, the foremost non-government and non-profit cancer research financer, which bestowed a grant of $384,262,652 to 630 significant projects in 2021. Moreover, BioProtect Ltd., an Israeli firm recognized for its groundbreaking bioabsorbable polymer spacer balloons, garnered $13 million from its Series D equity financing. This finance is courtesy of a preeminent global syndicate of venture investors, to continue the multicenter FDA clinical trial of BioProtect’s star product, the ProSpace balloon spacer, designed to offer radiation therapy protection to prostate cancer patients. In a similar vein, Endosight, the pioneer in augmented-reality-guided ablative systems, committed 20% of its received funding from private firms. Collectively, these investments from multiple organizations underpin the emergence of new technologies and devices, thereby reinforcing the growth of the interventional oncology devices market.
What Are the Major Segments of the Interventional Oncology Devices Market?
1) By Product: Embolization Devices, Ablation Devices, Support Devices
2) By procedure: Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial Chemoembolization (TACE), Transcatheter Arterial Radioembolization (TARE), Selective Internal Radiation Therapy (SIRT), Transcatheter Arterial Embolization (TAE), Bland Embolization
3) By Cancer Type: Liver Cancer, Kidney Cancer, Lung Cancer, Bone Cancer, Other Cancer Types
What New Trends Are Transforming the Interventional Oncology Devices Market?
Prominent businesses are concentrating on implementing robotics technology in interventional oncology equipment to enhance efficacy. This robotic system combines image-guided planning and navigation with the implementation of diverse devices to the designated body part more accurately and efficiently. For example, Quantum Surgical’s Epione intervention oncology robotics platform was given approval by the U.S. Food and Drug Administration in March 2022.
Order Now for Fast Delivery of Your Interventional Oncology Devices Market Report!
Which Regions Are Driving Growth in the Interventional Oncology Devices Market?
North America was the largest region in the interventional oncology devices market in 2023. Asia-Pacific was the second largest region in the global interventional oncology devices market report. The regions covered in the interventional oncology devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The Interventional Oncology Devices Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the interventional oncology devices market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The Interventional Oncology Devices Market Include
1. Interventional Oncology Devices Market Executive Summary
2. Interventional Oncology Devices Market Segments
3. Interventional Oncology Devices Market Size And Template Market Growth Rate
4. Key Interventional Oncology Devices Market Trends
5. Major Interventional Oncology Devices Market Drivers
……
25. Key Mergers And Acquisitions In The Interventional Oncology Devices Market
26. Top Interventional Oncology Devices Companies
27. Interventional Oncology Devices Market Opportunities And Strategies
28. Interventional Oncology Devices Market, Conclusions And Recommendations
29. Appendix
Discover Related Reports by The Business Research Company:
Transport Services Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/transport-services-global-market-report
Shipping Containers Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/shipping-containers-global-market-report
Oncology Molecular Diagnostics Global Market Report 2024
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
